Philips and Corindus tackle interventional cardiology

Royal Philips Electronics and Corindus established an alliance agreement to add Corindus’ robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries (percutaneous coronary interventions) to Philips’ interventional cardiology systems.

Natick, Mass.-based Corindus’ robotic-assisted systems for interventional cardiology procedures complement Philips’ interventional imaging and clinical informatics, the companies said. As part of the alliance agreement, Philips has acquired a minority stake in Corindus, according to Amsterdam-based Philips.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.